Workshop: Kinase Ligand Design

webinar

Thu, 01 Feb 2024, 16:00 CET (Berlin)

Dr. Alexander Neumann, BioSolveIT

Workshop: Kinase Ligand Design

Kinases stand out as a popular focus in drug development. Their popularity is evident from the numerous FDA approvals granted to compounds targeting these specific proteins. The associated design process often integrates computational approaches such as molecular modeling and structure-based drug design, reflecting the dynamic and evolving landscape of kinase-targeted drug development.

This BioSolveIT workshop is dedicated to elucidating the basics of selective kinase inhibitor design, as well as the application of advanced techniques to optimize lead structures. Encompassing both the 3D structure-based and the 2D ligand-based realms, we will present and discuss several examples illustrating idea generation methods for hinge binders and the adjacent core regions. These methods will include fragment-based growing (FBDD), scaffold hopping, Chemical Space exploration involving trillions of possibilities, and various other strategies facilitated by BioSolveIT tools.

Drug discovery beginners, veterans, and medicinal chemistry enthusiasts are invited to join this highly informative workshop and the subsequent discussion.

Participants can request a certificate of attendance to confirm their completion of the event to furthering their knowledge and skills in the specified subject matter.

Current news

category
Events
Boston Event: Expanding Molecular Diversity with CORE
September 15, 2026 17:27 CEST
Chemical Space Exploration Meets AI in Boston BioSolveIT and Onepot.AI invite you to an evening of science, drinks, and conversation at D16, the speakeasy beneath Dillon’s in Boston. Join us on September 30, 2026, for two very concise presentations exploring how ultra-large Chemical Spaces and artificial intelligence can open new...
Read on
category
Events
Beyond the Flatland: sp³-Rich Fragments Unlock Novel Kinase Chemotypes: Free Webinar!
September 15, 2026 10:40 CEST
Kinases are among the most intensively pursued target families in drug discovery, yet the chemical matter screened against them remains surprisingly narrow. Conventional kinase-focused libraries are dominated by flat, heteroaromatic compounds, while saturated, three-dimensional molecules stay largely underexplored. That narrow structural diversity makes it harder to find genuinely novel chemotypes,...
Read on
LifeCheMyriads by Life Chemicals - Access now with our tools
August 31, 2026 09:39 CEST
LifeCheMyriads brings an actionable, novelty-focused universe of 53 billion on-demand synthesizable compounds directly into your workflow. Created by Life Chemicals, this collection was built from 210 in-house-validated reaction protocols and 20,000+ proprietary and commercially available building blocks. The result is a medicinal chemistry-driven catalog spanning more than 340 million unique...
Read on